India HPV Campaign Crosses 80 Lakh Doses
Analysis based on 27 articles · First reported Sep 11, 2026 · Last updated Sep 11, 2026
The milestone is a public-health achievement that modestly supports demand for HPV vaccine makers such as Merck & Co., whose Gardasil-4 is used in the campaign, though the free government procurement limits near-term revenue upside. Broader market impact is minimal, as the event is a domestic healthcare program update rather than a major economic or corporate development.
India has crossed 80 lakh (8 million) Human Papillomavirus (HPV) vaccine doses administered under the National HPV Vaccination Campaign, the Bangladesh — Ministry of Health and Family Welfare said on Friday. The campaign was launched by Prime Minister Narendra Modi on February 28, 2026, to provide free, voluntary, single-dose Gardasil-4 HPV vaccination to 14-year-old girls at government health facilities, with parental consent. The vaccine prevents cervical cancer, the second most common cancer among women in India. According to Registrar General of India 2021 estimates, approximately 1.2 crore girls form the annual cohort of 14-year-olds eligible to benefit each year. India — Uttar Pradesh leads with over 22 lakh adolescent girls vaccinated. India — Gujarat, India — Madhya Pradesh, India — Mizoram and India — Uttar Pradesh have achieved 100 percent coverage of their identified target populations; India — Bihar, India — Andhra Pradesh and India — Assam have crossed 90 percent; India — Karnataka has achieved over 85 percent; and India — Chhattisgarh, India — Sikkim, India — Kerala, India — Telangana and India — Odisha have crossed 60 percent. Vaccination sessions are supervised by trained medical officers, with sites linked to 24x7 adverse events following immunisation management centres. The U-WIN digital platform tracks coverage and identifies gaps. Health workers including ASHAs and ANMs, teachers, and experts from institutions such as All India Institutes of Medical Sciences supported mobilisation. The World Health Organization reports cervical cancer caused around 604,000 new cases and 280,000 deaths globally in 2024. India reports over 120,000 new cases and nearly 80,000 fatalities annually. The campaign is entering its final phase, with focus on reaching remaining eligible beneficiaries.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard